DENIS CHEM LAB LTD Q1 RESULTS
Paytm shares jump another 5% despite denying talks with Adani
Paytm shares rose 5% amid reports of deal talks between Paytm CEO and billionaire. Shares hit upper circuit limit despite company's denial of discussions.
GIFT Nifty down 80 points; here's the trading setup for today's session
"Nifty has been consolidating in a broad range for the third consecutive day as investors remain watchful ahead of the big election outcome next week. We expect the Nifty to remain sideways to marginally positive on the back of reduced FII selling, prediction of above normal monsoon and last leg of Q4 results," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?
Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This rise came as brokerages such as Motilal Oswal and InCred expressed bullish sentiment towards the stock, following the company's impressive performance in Q4, where it reported a 68% year-on-year increase in profits, reaching Rs 538 crore.
Best Centrifuge Machines in India for Professional Labs and Home Projects (2024)
Are you looking for a centrifuge machine? If so, then we welcome you to go through our article where we have curated a list of the best centrifuge machines in India. For professional lab or home use, no matter why you wish to buy one, this article has the right links to place your order.
Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 crore
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
Will Nifty hit fresh record high before elections? That depends on these 5 factors
The week may remain lacklustre on the data front as no major economic data releases are scheduled in both the US as well as the Indian market. Indian investors are likely to focus more on the ongoing earnings season as well as stock specific developments. Nifty and Sensex have reached all-time highs driven by US Fed data and expert insights. Key factors that will shape market outlook.
- Go To Page 1
Jyothy Labs Q4 Results: Net profit rises 32% YoY to Rs 78 crore
Homegrown FMCG firm Jyothy Labs Ltd on Wednesday reported a 31.9 per cent increase in consolidated net profit to Rs 78.15 crore in the March quarter. The company had posted a consolidated net profit of Rs 59.26 crore in the same quarter a year earlier, Jyothy Labs Ltd said in a regulatory filing.
Dr Lal PathLabs shares zoom 8% after Q4 results. Should you buy or sell?
Dr Lal PathLabs saw an 8% surge in shares to Rs 2,539.65 on the BSE following a 51% YoY increase in net profit to Rs 86 crore for Q4FY24. Analysts have varying opinions, with Kotak and JM Financial maintaining positive outlooks, while Goldman Sachs remains cautious.
Dr Lal PathLabs Q4 Results: Net profit rises 51% YoY to Rs 86 crore on improved volumes of diagnostic tests
Dr Lal PathLabs on Friday reported a 51% year-on-year (YoY) jump in net profit to Rs 86 crore in the quarter ended March 2024 led by improved volumes of diagnostic tests.
Dr. LalPath Labs Q4 Reslts: Firm posts higher profit on healthy testing demand
Its shares climbed as much as 7.8% after the results before trimming some gains to trade up about 6%. Rival Metropolis Healthcare was up about 2% and Thyrocare Technologies gained about 1%.
Zee to announce Q4 earnings, likely dividend payout on May 17
In 2024, so far the shares have tanked over 53%, and the counter hit its 52-week low of Rs 130.50 on Wednesday taking the declines to 56% from its 52-week high of Rs 299.70, which it hit in December last year.
Dr Reddy's Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share
Dr Reddy's Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.
Q4 results today: Ambuja Cements, Adani Wilmar among 18 companies to announce earnings
Adani group leads Q4 earnings with multiple companies reporting results today. Ambuja Cements expected to show growth, while Adani Wilmar anticipates revenue dip but higher operating profit.
Huawei Q1 Results: Chinese tech giant posts over fivefold rise in profits
Tech giant Huawei's profits surged over fivefold year-on-year in the first quarter of 2024, a company filing showed Tuesday, as the firm continues a rebound and bit into competitor Apple's sales in China. Huawei competitor Apple saw iPhone sales slump by 19 percent in the first quarter in China, Bloomberg reported, citing market research firm Counterpoint.
Q4 results this week: Adani group to lead as 211 companies will declare earnings
With 211 companies announcing quarterly results this week, investors are particularly watching out for major names like Kotak Mahindra Bank, DMart, Ultratech Cement, Indian Oil, and many others across various industries.
Q4 results: How LTTS, Cyient, Zensar Technologies and Laurus Labs fared in March quarter
LTTS reported 8% YoY growth in net profit at Rs 1,304 crore while the standalone revenue stood at Rs 9,647 crore, up by 9%.
Tata Elxsi Q4 Results: Net down 4.5% QoQ to Rs 197 crore; company added 1,500 employees in FY24
The engineering service provider also saw its Q4 revenue at Rs. 905.9 crore, down by 0.9% QoQ. This the first time after Q1 of FY21, where the company saw a sequential revenue decline. For the full fiscal its revenue grew by 13% on-year at Rs 3,552 crore.
Divis Labs Q3 Results: Profit rises 17% YoY to Rs 358 crore
Revenue from operations in the reporting period increased 9% year-on-year to Rs 1,855 crore, compared with Rs 1708 crore in the corresponding period of last year.
Divi’s Labs Q3 results today: Could there be any fireworks in the scorecard?
The consolidated net profit for the quarter is seen rising 33% YoY to Rs 407.40 crore, according to the average of estimates given by five brokerage firms.
Q3 Results Today: Divi’s Lab, ONGC, MCX among 170 companies to announce earnings
Among other important results will be those by Aurobindo Pharma, Chemcon Speciality Chemicals, Sai Silks (Kalamandir), Mawana Sugars, MM Forgings and Yatharth Hospital & Trauma Care Services.
Divi’s Labs Q3 preview: PAT may grow 33% YoY on favourable base; outlook eyed
The consolidated net profit for the quarter is seen rising 33% YoY to Rs 407.40 crore, according to the average of estimates given by five brokerage firms.
Dr. Lal PathLabs Q3 Results: Firm posts 54% jump in profit on flu, COVID tests
The October-December quarter encompasses the tail end of the monsoon as well as winter, which brings with them ailments such as influenza and stomach flu.
Laurus Labs shares crash 10% after missing Q3 estimates
In Q3, the company's revenue dropped 23% year-on-year (YoY) at Rs 1,195 crore while profit also dropped 89% YoY to Rs 23 crore.
Divi's Lab Q2 Results: Profit falls 29% YoY to Rs 348 crore, misses estimates
Revenue from operations rose 3% year-on-year (YoY) to Rs 1,909 crore in the July-September period. It was Rs 1,855 crore in the corresponding quarter of the previous year.
Dr Reddy's Labs Q2 Results: Co reports highest-ever net profit at Rs 1480 crore
Dr Reddy's on Friday reported its highest-ever quarterly net profit of Rs 1480 crore in Q2FY24, a jump of 33% year-on-year (YoY) driven by generics sales growth in the US and Europe.
Dr Reddy's Labs Q2 Results: Profit rises 33% YoY to Rs 1,480 crore, revenue up 9%
The company reported an EBITDA of Rs 2,181 crore in the September quarter, higher by 13% YoY. EBITDA margins in the same period came in at 31.7%.Segment-wise, revenue from the global generics business jumped 9% year-on-year to Rs 6,110 crore, primarily driven by North America and Europe.
Laurus Labs shares hit 10% lower circuit on week Q2 earnings
The pharma company reported a consolidated net profit of Rs 37 crore, which was down by Rs 84% year-on-year versus Rs 233.39 crore posted by the company in the year-ago period. However, the profit after tax (PAT) jumped over 38% on a quarter-n-quarter basis. The consolidated revenue for the reporting quarter stood at Rs 1,224 crore, down by 22% YoY excluding PO (purchase order), a growth of 18%.
Laurus Labs Q2 Results: Net profit nosedives 84% YoY to Rs 37 crore
Laurus Labs' revenue for the quarter ended September declined 22.3% YoY to Rs 1,224 crore in Q2FY24. The company's earnings before interest, taxes, depreciation and amortization dropped 58% YoY to Rs 188 crore, from Rs 448.9 crore in the year-ago period. The EBITDA margin was at 15.3% in Q2FY24 against 28.5% in the year-ago period.
Q1 Results Today: Laurus Labs, IEX and ACC
Laurus Labs Q1 consolidated net profit fell 90% YoY to INR25 crore due to lower sales and elevated expenses. The API business reported a 2% growth in revenues to INR597 crore, however, sequentially it experienced a 16% decline. Indian Energy Exchange recorded a 10% YoY rise in consolidated
Load More